Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Immunoblastic lymphosarcoma, a cytological and clinical entity?

G Mathé, D Belpomme, D Dantchev

Biomedicine / [Publiee Pour L'A.A.I.C.I.G.]

|November 1, 1975

Summary

Immunoblastic lymphosarcoma (ILS) is a distinct subtype of lymphosarcoma characterized by specific cell morphology and clinical features. This aggressive cancer presents unique diagnostic and prognostic challenges in hematologic oncology.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

COVID-19 and stillbirth: direct vs indirect effect of the pandemic.

Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology·2021

Same author

Does COVID-19 cause pre-eclampsia?

Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology·2021

Same author

Cesarean scar pregnancy is associated with abnormal implantation but not macroscopic myometrial invasion in early first trimester of pregnancy.

Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology·2021

Same author

Immunology of Aging: the Birth of Inflammaging.

Clinical reviews in allergy & immunology·2021

Same author

Maternal cardiovascular potential and kinetic energy indices in pre-eclamptic and small-for-gestational-age pregnancies.

Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology·2021

Same author

Perinatal and long-term outcome of fetal intracranial hemorrhage: systematic review and meta-analysis.

Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology·2021

Area of Science:

Hematologic Oncology
Immunopathology
Cytopathology

Background:

Lymphosarcomas (LS) encompass various lymphoid malignancies.
Immunoblastic lymphosarcoma (ILS) is a specific subtype with distinct cellular and clinical characteristics.
Understanding ILS is crucial for accurate diagnosis and treatment in hematologic malignancies.

Purpose of the Study:

To characterize 20 cases of immunoblastic lymphosarcoma (ILS).
To identify the cytological, etiological, clinical, and prognostic features of ILS.
To determine if ILS represents a distinct cytoclinical entity within lymphosarcomas.

Main Methods:

Cytohistological analysis of 20 lymphosarcoma cases.
Evaluation of T or B-cell markers and absence of reticulosarcoma features.

Related Experiment Videos

Conventional and scanning electron microscopy to study cell morphology.

Clinical data review including patient demographics, disease stage, and treatment response.

Main Results:

ILS cells exhibit specific morphology (large pyroninophilic/basophilic cells, polyribosomes) distinct from other LS.
ILS predominantly affects males (85%) and can present at advanced stages (Stage IV in 50%).
Chemotherapy resistance and a poor prognosis (median survival 8 months) were observed in ILS.
High rates of leukaemic conversion (45%) and vital organ infiltration were noted.

Conclusions:

Immunoblastic lymphosarcoma (ILS) is a distinct cytoclinical entity within lymphosarcomas.
ILS is characterized by specific cellular morphology, aggressive clinical behavior, and poor prognosis.
Further research is warranted to optimize treatment strategies for this aggressive hematologic malignancy.